- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00831064
A Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy
A Randomized Controlled Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy: Efficacy, Patient Tolerability and Safety
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adequate bowel preparation is imperative for diagnostic accuracy and therapeutic safety. Several bowel cleansing preparations have been approved by Health Canada and are commonly used prior to colonoscopy. Polyethylene glycol (PEG) has been considered to be the "gold standard" for bowel preparation. It is a nonabsorbable solution which passes through the bowel without net absorption or secretion. Significant fluid and electrolyte shifts are therefore avoided. However, the large volume (4 liters), the salty taste and the sulphur smell frequently lead to poor tolerability and compliance, sometimes resulting in inadequate bowel preparation. Several other bowel cleansing preparations have been developed and include sodium phosphate (NaP), magnesium citrate, and sodium picosulphate plus magnesium oxide (PSMC)-containing preparations. NaP is a low volume hyperosmotic solution which draws plasma water into the bowel lumen to promote colonic cleansing. As a result, significant fluid and electrolyte shifts can occur. The advantage of the low volume is better patient tolerance compared to PEG. However, even in healthy individuals severe electrolyte disturbances have been reported when the 2 required doses are taken 12 hours apart. Therefore Health Canada has recommended that 2 doses of NaP be taken 24 hours apart. Patients with renal failure, congestive heart failure and liver failure should avoid this preparation (Grade I A). PSMC is a hyperosmotic saline laxative which increases intraluminal volume resulting in increased intestinal motility. Magnesium, a constituent of PSMC, stimulates the release of cholecystokinin which also stimulates intestinal motility. Since magnesium is eliminated by the kidney, patients with renal insufficiency or failure should also avoid this preparation.
Many randomized controlled trials have compared the efficacy and tolerability of various bowel cleansing regimens. Studies comparing full-volume (4 liters) PEG with low-volume (2 liters) PEG combined with magnesium citrate or bisacodyl have demonstrated equal efficacy of colonic cleansing but with improved patient tolerance. However, there is little data on how low volume PEG compares with NaP. The only meta-analysis of twenty nine trials on optimal bowel preparation concluded that NaP was more effective in bowel cleansing than 4-liter PEG or PSMC. However, there were only three trials comparing NaP to PSMC that met inclusion and exclusion criteria in this meta-analysis and the results have been conflicting. Also there were only three trials comparing PEG to PSMC in this meta-analysis with inconclusive data. Moreover, the mean number of patients per trial was small at 223, with the highest number of patients in a trial at 500.
A consensus document prepared by three leading American gastrointestinal societies (American Society of Gastrointestinal Endoscopy, American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons) as well as a position paper by the Canadian Association of Gastroenterology identified the lack of an ideal bowel preparation which meets all these criteria. Furthermore, the need for further studies was identified in the following areas:
- Two-liter PEG vs NaP
- PSMC vs NaP
Outpatients who need to undergo routine colonoscopy will be recruited. Each patient will be randomly assigned to one of the four bowel preparations after they have given consent to participate in the study:
- Group 1. 4L PEG.
- Group 2. 2L PEG plus 4 tablets of bisacodyl.
- Group 3. 90 cc NaP.
- Group 4. PSMC plus 1 bottle of Mg-citrate (300 cc).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada
- University of Alberta Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female between the ages of 18 and 75.
- Planned elective outpatient colonoscopy.
Exclusion Criteria:
- History of renal insufficiency or abnormal creatinine clearance with GFR <59.
- History of congestive heart failure.
- History of acute coronary syndrome or unstable angina.
- History of liver cirrhosis or ascites.
- Chronic lasix therapy.
- History of colorectal resection.
- Known or suspected bowel obstruction, megacolon or ileus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: 1. 4L PEG only
4L PEG PO
|
PEG, bisacodyl, NaP, PSMC and Mg-citrate
|
ACTIVE_COMPARATOR: 2. 2L PEG plus bisacodyl
2L PEG PO + 4 tablets bisacodyl PO
|
PEG, bisacodyl, NaP, PSMC and Mg-citrate
|
ACTIVE_COMPARATOR: 3. NaP
90 cc NaP PO
|
PEG, bisacodyl, NaP, PSMC and Mg-citrate
|
ACTIVE_COMPARATOR: 4. PSMC plus Mg-citrate
PSMC plus 300 cc Mg-citrate PO
|
PEG, bisacodyl, NaP, PSMC and Mg-citrate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
bowel preparation quality as measured by the Ottawa scale
Time Frame: at the time of endoscopy
|
at the time of endoscopy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
electrolyte and renal function abnormalities
Time Frame: 2 sets of measurements will be obtained: prior to the start of bowel preparation and at the time of colonoscopy
|
2 sets of measurements will be obtained: prior to the start of bowel preparation and at the time of colonoscopy
|
patient tolerability of bowel preparation
Time Frame: at the time of colonoscopy
|
at the time of colonoscopy
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sander van Zanten, MD, University of Alberta
- Principal Investigator: Din a Kao, MD, University of Alberta
Publications and helpful links
General Publications
- Barkun A, Chiba N, Enns R, Marcon M, Natsheh S, Pham C, Sadowski D, Vanner S. Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol. 2006 Nov;20(11):699-710. doi: 10.1155/2006/915368.
- Sharma VK, Chockalingham SK, Ugheoke EA, Kapur A, Ling PH, Vasudeva R, Howden CW. Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation. Gastrointest Endosc. 1998 Feb;47(2):167-71. doi: 10.1016/s0016-5107(98)70351-7.
- Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc. 2004 Apr;59(4):482-6. doi: 10.1016/s0016-5107(03)02875-x. Erratum In: Gastrointest Endosc. 2004 Aug;60(2):326.
- American Society of Colon and Rectal Surgeons (ASCRS); American Society for Gastrointestinal Endoscopy (ASGE); Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE. A consensus document on bowel preparation before colonoscopy: prepared by a Task Force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc. 2006 Jul;20(7):1161. doi: 10.1007/s00464-006-3037-1. No abstract available.
- Rostom A, Jolicoeur E, Dube C, Gregoire S, Patel D, Saloojee N, Lowe C. A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc. 2006 Oct;64(4):544-52. doi: 10.1016/j.gie.2005.09.030.
- Schmidt LM, Williams P, King D, Perera D. Picoprep-3 is a superior colonoscopy preparation to Fleet: a randomized, controlled trial comparing the two bowel preparations. Dis Colon Rectum. 2004 Feb;47(2):238-42. doi: 10.1007/s10350-003-0027-4.
- Hookey LC, Vanner S. A review of current issues underlying colon cleansing before colonoscopy. Can J Gastroenterol. 2007 Feb;21(2):105-11. doi: 10.1155/2007/634125.
- Poon CM, Lee DW, Mak SK, Ko CW, Chan KC, Chan KW, Sin KS, Chan AC. Two liters of polyethylene glycol-electrolyte lavage solution versus sodium phosphate as bowel cleansing regimen for colonoscopy: a prospective randomized controlled trial. Endoscopy. 2002 Jul;34(7):560-3. doi: 10.1055/s-2002-33207.
- Frommer D. Cleansing ability and tolerance of three bowel preparations for colonoscopy. Dis Colon Rectum. 1997 Jan;40(1):100-4. doi: 10.1007/BF02055690.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1-Kao
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bowel Preparation
-
University of British ColumbiaCompletedEfficacy of Bowel Preparation | Ease of Bowel Preparation and Patient TolerabilityCanada
-
Alexandra Hospital, Athens, GreeceRecruitingBowel Preparation | Preparation for ColonoscopyGreece
-
Inje UniversityUnknownBOWEL PREPARATION (BOWEL CLEANSING)Korea, Republic of
-
Jinling Hospital, ChinaRecruiting
-
Ferring PharmaceuticalsRecruitingBowel PreparationUnited States
-
Taejoon Pharmaceutical Co., Ltd.Completed
-
Azienda USL ModenaCompleted
-
Shandong UniversityUnknownBowel PreparationChina
-
Samsung Medical CenterCompletedBowel PreparationKorea, Republic of
Clinical Trials on colonoscopy bowel prep
-
Children's Mercy Hospital Kansas CityUniversity of North CarolinaWithdrawn
-
Boston Urogynecology AssociatesUnknown
-
The Cleveland ClinicCompletedColonoscopy | EsophagogastroduodenoscopyUnited States
-
IRCCS San RaffaeleRecruitingUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereItaly
-
Randers Regional HospitalCompleted
-
S. Andrea HospitalCompletedColonoscopy: Bowel Preparation
-
University of British ColumbiaCompletedEfficacy of Bowel Preparation | Ease of Bowel Preparation and Patient TolerabilityCanada
-
Harminder SinghCompletedColonoscopy | Patient ComplianceCanada
-
Methodist Health SystemRecruitingDiverticular BleedingUnited States